Medica and Axon Diagnostics Merge to Enhance Diagnostic Services in the UK

Medica and Axon Diagnostics Merge to Enhance Diagnostic Services in the UK

Medica’s extensive network of clinicians will combine with Axon’s advanced technology platform to serve over 2.5 million patients, across the majority of NHS Acute Trusts

Medica Group (Medica), the UK’s largest teleradiology provider and a leader in digital pathology and telemedicine, today announced that it has entered into an agreement that adds Axon Diagnostics (Axon) to the Medica Group. This integration reflects a shared vision to accelerate innovation and expand access to high quality remote diagnostic reporting across the NHS and independent healthcare sector. As Axon joins Medica, it will also welcome its sister company, MITIS Health, whose Clinical Desktop technology supports highfidelity remote reporting valued by many NHS Trusts and Axon clients.

Medica’s extensive pool of specialist clinicians, supported by its proven clinical governance and infrastructure, will be strengthened by Axon’s innovative technology platform and workflow tools, together with the Clinical Desktop technology from MITIS. Axon’s technologies are widely recognised for their agility, user-centric design, and access to Clinical Desktop technology from MITIS that enables high-performance remote desktop access, allowing clinicians to work seamlessly and securely from any appropriate location. Axon also brings a pool of high-quality clinicians, who have earned an outstanding reputation for quality of service and responsiveness. Bringing these complementary strengths together will provide increased capacity, enabling the combined company to deliver an enhanced experience for clients and their patients across the country, at greater speed. It also means the company is well-positioned to accelerate innovation in areas such as AI-enabled reporting, workflow optimisation, and expanded diagnostic services.

Together, the organisations will offer the largest clinical reporting network in the UK, covering major diagnostic subspecialties and providing proven capacity to support routine and urgent cases, including periods of surge demand. The company will serve over 2.5 million patients across 55% of all NHS Trusts.

Both organisations remain committed to acting as trusted strategic partners to healthcare providers, offering transparency, consistency and measurable improvements in patient outcomes. As such, healthcare providers will continue to work with the same trusted teams, ensuring consistency of service while benefiting over time from the expanded capabilities of the combined organisation. Axon’s advanced reporting technology will be incorporated into Medica’s service offering through a phased integration programme, while clinicians from both organisations will have access to a broader case mix and enhanced tools as systems gradually integrate. The combined scale and streamlined workflows will also support greater efficiency and cost effectiveness for clients, aligning with NHS long term priorities. The integration of Axon into Medica will deliver a resilient, flexible service that keeps patients at the heart of every decision.

Andrew Cannon, Chief Executive Officer of Medica Group, said:   
“This merger marks a significant milestone for Medica, and we are proud to welcome Axon into the Medica Group. The Axon team has built an exceptional business in a remarkably short time, earning the trust of clients through first-rate service, agility and a deep commitment to quality. Bringing Axon into Medica strengthens our position as the UK’s leading diagnostics provider. Clients will continue to receive the excellent service they rely on, now supported by greater capacity and advanced reporting technology. We look forward to building a compelling future together, driving further innovation and delivering outstanding patient care at the core of our mission.”

Rahul Mehta, Chief Executive Officer of Axon Diagnostics, said:   
“Axon was founded to push the boundaries of diagnostic innovation, and joining Medica enables us to amplify that mission. This merger combines our technology and agile approach with Medica’s scale and clinical excellence, meaning more patients will benefit from faster and smarter reporting. We’re excited to enter this next chapter together, bringing our teams and clients with us into the Medica Group as we continue building trusted, high quality diagnostic services.”

Medica and Axon are currently implementing a phased integration plan that will bring together systems, teams and best practices in a structured and transparent way.